Fulgent Genetics, Inc.
FLGT
$14.67
$0.040.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.51M | -42.98M | -51.02M | -40.78M | -42.71M |
| Total Depreciation and Amortization | 24.12M | 24.20M | 24.09M | 24.18M | 24.93M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.39M | 50.04M | 59.72M | 47.89M | 46.08M |
| Change in Net Operating Assets | -117.63M | -29.74M | -57.87M | -21.94M | -7.24M |
| Cash from Operations | -101.64M | 1.52M | -25.09M | 9.36M | 21.06M |
| Capital Expenditure | -22.57M | -21.37M | -34.86M | -40.98M | -40.32M |
| Sale of Property, Plant, and Equipment | 5.00K | 5.00K | 40.00K | 57.00K | 313.00K |
| Cash Acquisitions | 3.78M | 3.78M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.17M | 90.35M | 97.48M | 57.48M | -18.35M |
| Cash from Investing | 111.37M | 72.76M | 62.66M | 16.56M | -58.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -870.00K | -918.00K | -966.00K | -1.48M | -1.77M |
| Issuance of Common Stock | 1.00K | 51.00K | 51.00K | 51.00K | 51.00K |
| Repurchase of Common Stock | -13.92M | -13.72M | -13.79M | -11.78M | -3.12M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.79M | -14.58M | -14.70M | -13.21M | -4.85M |
| Foreign Exchange rate Adjustments | 105.00K | -104.00K | 38.00K | 25.00K | -55.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.95M | 59.60M | 22.90M | 12.74M | -42.19M |